Sargent Bickham Lagudis’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$47.4K Hold
806
﹤0.01% 449
2022
Q3
$46K Buy
806
+33
+4% +$1.92K ﹤0.01% 425
2022
Q2
$42K Buy
773
+1
+0.1% +$58 ﹤0.01% 454
2022
Q1
$44K Hold
772
﹤0.01% 479
2021
Q4
$36K Buy
772
+1
+0.1% +$46 ﹤0.01% 507
2021
Q3
$32K Buy
771
+1
+0.1% +$43 ﹤0.01% 526
2021
Q2
$34K Buy
770
+220
+40% +$10.2K ﹤0.01% 519
2021
Q1
$26K Buy
550
+171
+45% +$7.57K ﹤0.01% 546
2020
Q4
$15K Sell
379
-37
-9% -$1.32K ﹤0.01% 598
2020
Q3
$12K Buy
416
+1
+0.2% +$28 ﹤0.01% 573
2020
Q2
$11K Sell
415
-111
-21% -$2.89K ﹤0.01% 563
2020
Q1
$12K Buy
526
+38
+8% +$1.04K ﹤0.01% 530
2019
Q4
$14K Buy
488
+145
+42% +$3.84K ﹤0.01% 568
2019
Q3
$10K Sell
343
-28
-8% -$810 ﹤0.01% 558
2019
Q2
$11K Buy
+371
New +$9.98K ﹤0.01% 575

Other funds holding CTVA

Sargent Bickham Lagudis's CTVA Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Corteva (CTVA) position steady in Q4 2022 at 806 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

Sargent Bickham Lagudis first reported a position in CTVA in Q2 2019 and has held it in 15 quarters since. 1,301 funds tracked by Wall St. Rank hold CTVA as of Q4 2022.

  • Sargent Bickham Lagudis held 806 shares of Corteva worth $47.4K as of Q4 2022.
  • Sargent Bickham Lagudis left its Corteva share count unchanged in Q4 2022.
  • Corteva made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #449 holding.
  • Sargent Bickham Lagudis first reported a position in Corteva in Q2 2019 and has held it in 15 quarters since.
  • 1,301 funds tracked by Wall St. Rank held Corteva as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.